SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-053525
Filing Date
2021-10-19
Accepted
2021-10-19 16:45:28
Documents
14
Period of Report
2021-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149083-8k_optimizerx.htm   iXBRL 8-K 34023
2 LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND WILLIAM J. FEBBO ea149083ex10-1_optimizerx.htm EX-10.1 15194
3 GRAPHIC ex10-1_001.jpg GRAPHIC 4575
  Complete submission text file 0001213900-21-053525.txt   238184

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20211015.xsd EX-101.SCH 3031
5 XBRL LABEL FILE oprx-20211015_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE oprx-20211015_pre.xml EX-101.PRE 22793
7 EXTRACTED XBRL INSTANCE DOCUMENT ea149083-8k_optimizerx_htm.xml XML 3755
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 211331620
SIC: 7389 Services-Business Services, NEC